» Articles » PMID: 38854471

Kaempferol Ameliorates Metabolic Syndrome by Inhibiting Inflammation and Oxidative Stress in High-fat Diet-induced Obese Mice

Overview
Journal Nutr Res Pract
Date 2024 Jun 10
PMID 38854471
Authors
Affiliations
Soon will be listed here.
Abstract

Background/objectives: Kaempferol (Ka) is one of the most widely occurring flavonoids found in large amounts in various plants. Ka has anti-obesity, antioxidant, and anti-inflammatory effects. Despite the numerous papers documenting the efficacy of Ka, some controversy remains. Therefore, this study examined the impact of Ka using 3T3-L1 and high-fat diet-induced obese mice.

Materials/methods: 3T3-L1 cells were treated with 50 μM Ka from the initiation of 3T3-L1 differentiation at D0 until the completion of differentiation on D8. Thirty male mice (C57BL/6J, 4 weeks old) were divided into 3 groups: normal diet (ND), high-fat diet (HFD), and HFD + 0.02% (w/w) Ka (Ka) group. All mice were fed their respective diets for 16 weeks. The mice were sacriced, and the plasma and hepatic lipid levels, white adipose tissue weight, hepatic glucose level, lipid level, and antioxidant enzyme activities were analyzed, and immunohistochemistry staining was performed.

Results: Ka suppressed the hypertrophy of 3T3-L1 cells, and the Ka-supplemented mice showed a significant decrease in perirenal, retroperitoneal, mesenteric, and subcutaneous fat compared to the HFD group. Ka supplementation in high-fat diet-induced obese mice also improved the overall blood lipid concentration (total cholesterol, non-high-density lipoprotein-cholesterol, phospholipids, and apolipoprotein B). Ka supplementation in high-fat-induced obesity mice reduced hepatic steatosis and insulin resistance by modulating the hepatic lipid (glucose-6-phosphate dehydrogenase, fatty acid synthase, malic enzyme, phosphatidate phosphohydrolase, and β-oxidation) activities and glucose (glucokinase, phosphoenolpyruvate carboxykinase, and G6pase)-regulating enzymes. Ka supplementation ameliorated the erythrocyte and hepatic mitochondrial HO and inflammation levels (plasma tumor necrosis factor-alpha, monocyte chemoattractant protein-1, interleukin-6, and interferon-gamma and fibrosis of liver and epididymal fat).

Conclusion: Ka may be beneficial for preventing diet-induced obesity, inflammation, oxidative stress, and diabetes.

References
1.
Arfian N, Setyaningsih W, Romi M, Sari D . Heparanase upregulation from adipocyte associates with inflammation and endothelial injury in diabetic condition. BMC Proc. 2020; 13(Suppl 11):17. PMC: 6912933. DOI: 10.1186/s12919-019-0181-x. View

2.
Yu S, Shun C, Chen T, Chen Y . 3-O-beta-D-glucosyl-(1-->6)-beta-D-glucosyl-kaempferol isolated from Sauropus androgenus reduces body weight gain in Wistar rats. Biol Pharm Bull. 2006; 29(12):2510-3. DOI: 10.1248/bpb.29.2510. View

3.
Park K, Gross M, Lee D, Holvoet P, Himes J, Shikany J . Oxidative stress and insulin resistance: the coronary artery risk development in young adults study. Diabetes Care. 2009; 32(7):1302-7. PMC: 2699736. DOI: 10.2337/dc09-0259. View

4.
Paglia D, Valentine W . Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med. 1967; 70(1):158-69. View

5.
Juhan-Vague I, Alessi M, Mavri A, Morange P . Plasminogen activator inhibitor-1, inflammation, obesity, insulin resistance and vascular risk. J Thromb Haemost. 2003; 1(7):1575-9. DOI: 10.1046/j.1538-7836.2003.00279.x. View